Walgreens (WAG) Feb. Sales Rise 3.2%, Comps Up 0.4%
Tweet
Share
E-mail
Walgreens (NYSE: WAG) (NASDAQ: WAG) had February sales of $5.31 billion, an increase of 3.2 percent from $5.14 billion for the same month in 2009. Sales in comparable stores (those open at least a year) increased 0.4 percent.
February pharmacy sales increased 3.7 percent, while comparable pharmacy sales increased 0.9 percent. Comparable pharmacy sales were negatively affected by 2.4 percentage points due to generic drug introductions in the last 12 months and a lower incidence of flu compared with February 2009. Pharmacy sales accounted for 64.5 percent of total sales for the month.
Prescriptions filled at comparable stores increased 3.6 percent in February, including 1.5 percentage points due to more patients filling 90-day prescriptions and 0.3 percentage points due to H1N1 flu shots. There was no impact on comparable prescriptions filled in the month due to calendar day shifts.
Total front-end sales increased 4.5 percent in February, while comparable store front-end sales decreased 0.6 percent. Front-end sales were impacted by continued weak demand for discretionary items and by lower incidence of flu.
Calendar year-to-date sales were $10.64 billion, an increase of 2.7 percent from $10.36 billion in 2009.
Fiscal 2010 year-to-date sales for the first six months were $33.34 billion, up 6.1 percent from $31.42 billion.
Walgreens opened seven stores during February, acquired 11 and closed one.
February pharmacy sales increased 3.7 percent, while comparable pharmacy sales increased 0.9 percent. Comparable pharmacy sales were negatively affected by 2.4 percentage points due to generic drug introductions in the last 12 months and a lower incidence of flu compared with February 2009. Pharmacy sales accounted for 64.5 percent of total sales for the month.
Prescriptions filled at comparable stores increased 3.6 percent in February, including 1.5 percentage points due to more patients filling 90-day prescriptions and 0.3 percentage points due to H1N1 flu shots. There was no impact on comparable prescriptions filled in the month due to calendar day shifts.
Total front-end sales increased 4.5 percent in February, while comparable store front-end sales decreased 0.6 percent. Front-end sales were impacted by continued weak demand for discretionary items and by lower incidence of flu.
Calendar year-to-date sales were $10.64 billion, an increase of 2.7 percent from $10.36 billion in 2009.
Fiscal 2010 year-to-date sales for the first six months were $33.34 billion, up 6.1 percent from $31.42 billion.
Walgreens opened seven stores during February, acquired 11 and closed one.
You May Also Be Interested In
- Optimum Communications gets NYSE non-compliance notice over stock price
- Z Squared outlines AI power strategy and Paradox Data acquisition
- Evogene chairman to address dissident shareholders on results call
Create E-mail Alert Related Categories
Corporate News, Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
